Teaching Neuroimages: COVID-19–Associated Acute Disseminated Encephalomyelitis With Corpus Callosal Hemorrhage
Citation Manager Formats
Make Comment
See Comments

A 55-year-old man with severe coronavirus disease 2019 (COVID-19) required ventilation and hemofiltration. Central venous catheter thrombosis necessitated heparin infusion. On day 20 postadmission, impaired conscious level, complex ophthalmoplegia, and hyperreflexia prompted noncontrast neuroimaging, demonstrating corpus callosal and right subinsular hemorrhage with diffuse white matter signal change (figure). CSF analysis was not performed due to clinical concerns regarding raised intracranial pressure. Administration of high-dose corticosteroids led to clinical and radiologic improvement (figure).
Initial MRI and CT with arrows highlighting peripheral low signal on T2* (A), abnormal diffusion (B), high T1 (C), and increased attenuation (D) within the corpus callosum splenium. Confluent high FLAIR (E) and T2 (F and G) abnormality and low attenuation (H) are noted within the deep cerebral white matter. Improved appearances at 2 weeks are seen (I–L).
The differential diagnosis of infective splenial lesions is presented (table).1 We consider the likely diagnosis to be acute disseminated encephalomyelitis with hemorrhage, adding to the clinical spectrum of neurologic complications of COVID-19 and highlighting the possibility of favorable outcome.2
Differential Diagnosis for Infective splenial Lesions
Study Funding
No targeted funding reported.
Disclosure
The authors report no disclosures relevant to the manuscript. Go to Neurology.org/N for full disclosures.
Appendix Authors

Footnotes
Go to Neurology.org/N for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.
↵* These authors contributed equally to this work.
Teaching slides links.lww.com/WNL/B251
- © 2020 American Academy of Neurology
References
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Nicole Sur and Dr. Mausaminben Hathidara
► Watch
Related Articles
Topics Discussed
Alert Me
Recommended articles
-
Views & Reviews
Presentations and mechanisms of CNS disorders related to COVID-19Marta Bodro, Yaroslau Compta, Raquel Sánchez-Valle et al.Neurology: Neuroimmunology & Neuroinflammation, December 11, 2020 -
Article
Neurologic and neuroimaging findings in patients with COVID-19A retrospective multicenter studyStéphane Kremer, François Lersy, Mathieu Anheim et al.Neurology, July 17, 2020 -
Review
Potential Neurologic Manifestations of COVID-19Anna S. Nordvig, Kathryn T. Fong, Joshua Z. Willey et al.Neurology: Clinical Practice, June 30, 2020 -
Review
Acute Hemorrhagic Encephalitis Related to COVID-19Alan Chalil, Carmen S. Baker, Robert B. Johnston et al.Neurology: Clinical Practice, July 08, 2020